vs
Side-by-side financial comparison of Envela Corp (ELA) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $80.5M, roughly 1.0× Envela Corp). Envela Corp runs the higher net margin — 7.4% vs -38.1%, a 45.5% gap on every dollar of revenue. On growth, Envela Corp posted the faster year-over-year revenue change (66.6% vs 20.2%). Over the past eight quarters, Envela Corp's revenue compounded faster (42.1% CAGR vs 24.8%).
Envela Corporation is a U.S.-based company that provides recommerce services aimed at extending product lifecycles and reducing resource consumption. The company operates through two primary segments: consumer and commercial.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
ELA vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $80.5M | $83.1M |
| Net Profit | $6.0M | $-31.6M |
| Gross Margin | 20.5% | 64.9% |
| Operating Margin | 9.4% | -4.1% |
| Net Margin | 7.4% | -38.1% |
| Revenue YoY | 66.6% | 20.2% |
| Net Profit YoY | 274.6% | -27.9% |
| EPS (diluted) | $0.22 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $80.5M | $76.4M | ||
| Q3 25 | $57.4M | $83.3M | ||
| Q2 25 | $54.9M | $79.2M | ||
| Q1 25 | $48.3M | $69.2M | ||
| Q4 24 | $48.3M | $68.2M | ||
| Q3 24 | $46.9M | $58.4M | ||
| Q2 24 | $45.3M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $6.0M | $-29.8M | ||
| Q3 25 | $3.4M | $-21.4M | ||
| Q2 25 | $2.8M | $-19.6M | ||
| Q1 25 | $2.5M | $-24.7M | ||
| Q4 24 | $1.6M | $-18.9M | ||
| Q3 24 | $1.7M | $-21.0M | ||
| Q2 24 | $1.6M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | 20.5% | 60.6% | ||
| Q3 25 | 22.8% | 64.8% | ||
| Q2 25 | 22.6% | 65.4% | ||
| Q1 25 | 24.8% | 63.9% | ||
| Q4 24 | 23.1% | 64.0% | ||
| Q3 24 | 24.4% | 63.2% | ||
| Q2 24 | 25.1% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 9.4% | -40.6% | ||
| Q3 25 | 7.3% | -27.8% | ||
| Q2 25 | 5.9% | -28.0% | ||
| Q1 25 | 6.5% | -39.7% | ||
| Q4 24 | 3.9% | -28.9% | ||
| Q3 24 | 4.3% | -38.4% | ||
| Q2 24 | 4.2% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 7.4% | -39.1% | ||
| Q3 25 | 5.8% | -25.7% | ||
| Q2 25 | 5.0% | -24.7% | ||
| Q1 25 | 5.2% | -35.8% | ||
| Q4 24 | 3.3% | -27.6% | ||
| Q3 24 | 3.6% | -35.9% | ||
| Q2 24 | 3.5% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.22 | $-0.54 | ||
| Q3 25 | $0.13 | $-0.38 | ||
| Q2 25 | $0.11 | $-0.35 | ||
| Q1 25 | $0.10 | $-0.45 | ||
| Q4 24 | $0.07 | $-0.34 | ||
| Q3 24 | $0.06 | $-0.40 | ||
| Q2 24 | $0.06 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.6M |
| Total DebtLower is stronger | $9.9M | $51.7M |
| Stockholders' EquityBook value | $67.1M | $347.7M |
| Total Assets | $96.0M | $487.1M |
| Debt / EquityLower = less leverage | 0.15× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | — | $294.3M | ||
| Q2 25 | — | $302.7M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $9.9M | $51.6M | ||
| Q3 25 | $12.5M | $51.6M | ||
| Q2 25 | $13.0M | $51.5M | ||
| Q1 25 | $13.2M | $51.5M | ||
| Q4 24 | $13.5M | $51.5M | ||
| Q3 24 | $13.8M | $51.4M | ||
| Q2 24 | $14.3M | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $67.1M | $365.9M | ||
| Q3 25 | $61.1M | $380.3M | ||
| Q2 25 | $57.8M | $385.8M | ||
| Q1 25 | $55.1M | $389.2M | ||
| Q4 24 | $52.7M | $402.2M | ||
| Q3 24 | $51.1M | $241.2M | ||
| Q2 24 | $50.2M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $96.0M | $508.1M | ||
| Q3 25 | $90.9M | $511.5M | ||
| Q2 25 | $82.7M | $513.1M | ||
| Q1 25 | $79.7M | $519.4M | ||
| Q4 24 | $77.9M | $534.0M | ||
| Q3 24 | $77.4M | $374.1M | ||
| Q2 24 | $73.8M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.15× | 0.14× | ||
| Q3 25 | 0.20× | 0.14× | ||
| Q2 25 | 0.23× | 0.13× | ||
| Q1 25 | 0.24× | 0.13× | ||
| Q4 24 | 0.26× | 0.13× | ||
| Q3 24 | 0.27× | 0.21× | ||
| Q2 24 | 0.29× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.5M | — |
| Free Cash FlowOCF − Capex | $-3.7M | — |
| FCF MarginFCF / Revenue | -4.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | -0.59× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-3.5M | $-10.3M | ||
| Q3 25 | $2.4M | $-6.6M | ||
| Q2 25 | $2.6M | $-15.0M | ||
| Q1 25 | $1.1M | $-17.0M | ||
| Q4 24 | $3.7M | $-32.4M | ||
| Q3 24 | $3.4M | $-18.8M | ||
| Q2 24 | $-789.5K | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-3.7M | $-12.2M | ||
| Q3 25 | $2.2M | $-9.5M | ||
| Q2 25 | $2.1M | $-17.8M | ||
| Q1 25 | $746.6K | $-18.8M | ||
| Q4 24 | $3.2M | $-33.6M | ||
| Q3 24 | $1.5M | $-19.0M | ||
| Q2 24 | $-1.3M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | -4.6% | -15.9% | ||
| Q3 25 | 3.8% | -11.4% | ||
| Q2 25 | 3.9% | -22.5% | ||
| Q1 25 | 1.5% | -27.2% | ||
| Q4 24 | 6.7% | -49.2% | ||
| Q3 24 | 3.1% | -32.6% | ||
| Q2 24 | -2.9% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 2.4% | ||
| Q3 25 | 0.4% | 3.4% | ||
| Q2 25 | 0.8% | 3.5% | ||
| Q1 25 | 0.8% | 2.7% | ||
| Q4 24 | 1.0% | 1.7% | ||
| Q3 24 | 4.2% | 0.4% | ||
| Q2 24 | 1.1% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | -0.59× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 0.94× | — | ||
| Q1 25 | 0.45× | — | ||
| Q4 24 | 2.34× | — | ||
| Q3 24 | 2.05× | — | ||
| Q2 24 | -0.50× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ELA
| Consumer Segment | $67.7M | 84% |
| Commercial Segment | $12.8M | 16% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
